Introduction {#s1}
============

Colorectal cancer is a major public health issue in developed countries and is becoming increasingly prevalent in Asia and Africa, with over 1.2 million new cases worldwide each year [@pone.0100133-Jemal1]. As other complex diseases, colorectal cancer is a complex trait driven by diverse etiologies involving in multiple environmental and genetic factors and their interactions [@pone.0100133-AlSohaily1]. Twin- and familial-based studies have provided clear evidence that approximately 35% of all CRC cases have a genetic component [@pone.0100133-AlSohaily1]. Of all CRC cases, \<5% can be accounted by a combination of some germline mutations with high penetrance, whereas most "sporadic" cases are due to large numbers of common variants with individually small effects [@pone.0100133-Hughes1].

Recently, genome-wide association studies (GWAS) have implicated multiple common single nucleotide polymorphisms (SNPs) in inherited predisposition to CRC [@pone.0100133-Peters1], [@pone.0100133-Tomlinson1]. The SNP rs4444235 at chromosome 14q22.2, mapping 9.4 kb upstream region of the gene encoding bone morphogenetic protein 4 (*BMP4)*, was firstly reported by a meta-analysis of GWAS data to be associated with CRC risk, with a combined OR of 1.11 (95% CI = 1.08--1.15, *P* = 8.1×10^−10^) [@pone.0100133-Houlston1]. BMP4 is an important member of the BMP signaling pathway, which involves in CRC development through regulation of colorectal stem cell differentiation [@pone.0100133-Hardwick1]. This SNP has been proposed to act as a cis-regulator of *BMP4* and thus conferred to CRC risk [@pone.0100133-Houlston1]. However, the following replication studies yielded inconsistent results, in part due to "winner curse" in the original report [@pone.0100133-Zhong1], "Proteus phenomenon" in replication data [@pone.0100133-Ioannidis1], heterogeneous ethnical population, and insufficient statistical power, among other issues.

Meta-analysis, by integrating published data, may be a powerful tool to clarify the inconsistencies across individual studies. Two meta-analyses have been performed to assess rs4444235 in CRC. The meta-analysis by Li et al. [@pone.0100133-Li1], including 19893 cases and 22106 controls, assessed multiple genetic models for the rs4444235, which would lead to multiple comparisons or erroneous mode specification without priori biological evidence. The other meta-analysis by Theodoratou et al. [@pone.0100133-Theodoratou1], including less samples (18607 cases and 19576 controls), utilized a maximum likelihood estimator to decipher plausible model for the rs4444235. However, in this meta-analysis, there was no subgroup analysis undertaken. To overcome the above mentioned shortcomings in the previous meta-analyses, we integrated published data from 28770 cases and 28234 controls, and performed an updated meta-analysis, using a comprehensive statistical strategy. The methodology of logistic regression was applied to estimate the most plausible genetic model in the metagen system [@pone.0100133-Bagos1]. The generalized odds ratio, based on model-free approach, was utilized to provide a global test of genetic association [@pone.0100133-Zintzaras1]. Stratified analyses were further performed to explore potential sources of heterogeneity. The core aim of this meta-analysis was to provide a more precise and robust evaluation for the role of rs4444235 polymorphism in genetic susceptibility of colorectal cancer.

Materials and Methods {#s2}
=====================

Search Strategy and Identification of Relevant Studies {#s2a}
------------------------------------------------------

This meta-analysis were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement ([Checklist S1](#pone.0100133.s001){ref-type="supplementary-material"}) [@pone.0100133-Moher1]. Genetic association studies regarding rs4444235 and colorectal cancer (CRC) risk were searched in the PubMed/MEDLINE and EMBASE databases through October 15, 2013, by using the combinations of the keywords: ("BMP4" or "rs4444235" or "14q22.2") and ("colorectal cancer" or "Colorectal neoplasmor" or "colon cancer" or "rectal cancer"). The similar search terms was also used for the WANFANG DATA and CNKI databases. The search was supplemented by review of reference lists for all relevant studies and review articles. All relevant reports identified were included without language restriction.

The following inclusion criteria should be fulfilled: (1) either case-control or nested case-control studies; (2) clear definition of colorectal cancer cases; (3) studies evaluating relationship between rs4444235 and CRC risk; (4) providing sufficient data to re-calculate the effect metrics, that was, numbers of genotypes in cases and controls. The authors were contacted via E-mail when eligible articles reported insufficient data. If they were unable to provide detailed data, those articles were excluded. Animal studies, reviews, conference abstracts, editorials and letters were excluded. If more than one ethnical population were in one report, each population was considered separately. Studies overlapping with other studies should be excluded, and the one with the most completed information was included. The first study on the association of rs4444235 by Houlston et al. was excluded [@pone.0100133-Houlston1], due to overlaps with the study by Tomlinson et al. [@pone.0100133-Tomlinson1]. The latter was chosen because of the larger sample.

Data Extraction {#s2b}
---------------

Data were extracted independently and in duplicate by 2 reviewers (L. Liu & Q. Su). The following data was extracted from each article according to a fixed protocol: the first author, publication year, study design, country, ethnicity, source of controls, numbers of cases and controls, mean age of cases, sex ratio, site/type of colorectal cancer, genotyping method, minor allele frequency (MAF), and frequency of genotypes in cases and controls.

Statistical Analysis {#s2c}
--------------------

Hardy-Weinberg equilibrium in controls was re-analyzed using the goodness-of-fit χ^2^ test (*P*\>0.05). The inverse variance method was applied to estimate the pooled frequency of the risk allele (the C allele) in various ethnical populations. The genetic effect of the rs4444235 in CRC susceptibility was assessed using the approaches described as below:

Metagen system has provided a general framework to decipher the most plausible genetic model for the rs4444235 that treated the genotypes as independent variables in a logistic regression under both fixed and random effects models [@pone.0100133-Bagos1]. Under fixed-effect model, two parameters, *θ* ~2~ and *θ* ~3~ were estimated using the logistic regression: logit (*π~ij~*) = *α~i~* +*θ~2~z~i2~*+*θ~3~z~i3~*, where *α~i~* was the indicator of study-specific fixed-effect, OR~TC/TT~ = exp(*θ~2~*), and OR~CC/TT~ = exp(*θ~3~*). In order to account for an additive component of heterogeneity, a random-effect logistic regression was performed using the GLLAMM module in STATA software via introducing a study-specific random coefficient: logit (*π~ij~*) = *α~i~* +(*θ~2~+ν~i2~*)*z~i2~*+(*θ~3+~ν~i3~)z~i3~*. The most plausible genetic model was determined using the following procedure: if *θ~2~* = *θ~3~* = 0, no significant genetic-association was suggested; if *θ~2~* = 0 and *θ~3~*\>0, a recessive genetic model was suggested; if *θ~2~* = *θ~3~\>*0, a dominant model was suggested; if *θ~3~*\>*θ~2~\>*0, a co-dominant model was suggested; if 2*θ~2~* = *θ~3~*, an additive model was likely. In this meta-analysis, the genetic model of rs4444235 was best fitted with an additive model. Then the per-allele OR of the C allele (additive model ) with corresponding 95% confidence interval (95% CI) was estimated in a logistic regression model, by assigning scores of 0, 1, and 2 to the AA, AC and CC genotypes, respectively. Between-study heterogeneity was assessed by the Cochran's χ^2^ based *Q* test and *I^2^* metric. If there was no heterogeneity (i.e., if the *Q* test was significant \[*P*\<0.1\] or *I^2^* was less than 25%), a fixed-effect model was used to pool the estimate; otherwise, a random-effect model was applied. To explore the sources of heterogeneity, stratified analyses were performed, if feasible, according to population ethnicity (Asians, Caucasians, and Africans), sources of controls (population- and hospital-based), study design (GWAS and replication study), and total sample size (≤2000 and \>2000).

Additionally, the generalized OR (OR~G~), based on a genetic model-free approach, was also introduced in this meta-analysis [@pone.0100133-Zintzaras1]. The OR~G~ utilized the complete genotype distribution to provide an estimate of overall gene-disease relationship, given that the mutational load was treated as a graded exposure. Heterogeneity was also assessed for OR~G~ metric and stratified analysis was also performed.

Sensitivity analysis was performed to assess the influence of single study on pooled estimates. Publication bias was tested by the Egger's regression test and Begg's funnel plot. Statistical analyses were conducted in ORGGASMA, metan and metagen modules in STATA software version 13.0. A *P* value of \<0.05 was considered statistically significant, except for estimation of between-study heterogeneity, where a significant level of 0.10 was applied.

Results {#s3}
=======

The Characteristic of Included Studies {#s3a}
--------------------------------------

[Figure 1](#pone-0100133-g001){ref-type="fig"} shows a flow diagram of the study selection process. The comprehensive search yielded 56 potentially relevant references. 18 articles were determined to be initially eligible by screening titles and abstracts. After further detailed evaluation, 7 duplicated articles [@pone.0100133-Houlston1], [@pone.0100133-Lubbe1], [@pone.0100133-Niittymaki1], [@pone.0100133-Niittymaki2], [@pone.0100133-Lubbe2], [@pone.0100133-Win1], [@pone.0100133-FernandezRozadilla1] and 3 articles with insufficient data [@pone.0100133-FernandezRozadilla1], [@pone.0100133-Thean1], [@pone.0100133-He1], [@pone.0100133-Lubbe3] were excluded. 1 article was excluded due to small sample size (92 cases and 96 controls) [@pone.0100133-Mates1]. 1 study in the article by Tomlinson et al. was excluded due to deviation with Hardy-Weinberg equilibrium [@pone.0100133-Tomlinson1]. Finally, a total of 7 articles with 19 studies of 28770 cases and 28234 controls were included in this meta-analysis [@pone.0100133-Tomlinson1], [@pone.0100133-FernandezRozadilla2], [@pone.0100133-vonHolst1], [@pone.0100133-Xiong1], [@pone.0100133-Ho1], [@pone.0100133-Kupfer1], [@pone.0100133-Li2]. The characteristics of these studies were summarized in [Table 1](#pone-0100133-t001){ref-type="table"}. Among the included studies, 15 studies were performed in Caucasians, 3 studies in Asians, and 1 study in Africans.

![Flow chart of study selection process.](pone.0100133.g001){#pone-0100133-g001}

10.1371/journal.pone.0100133.t001

###### Characteristics of included studies in the meta-analysis of rs4444235 and colorectal cancer.

![](pone.0100133.t001){#pone-0100133-t001-1}

  First author                                               Publication year   Ethnicity   Study design   Source of controls   MAF in controls   Cases   Controls                       
  --------------------------------------------------------- ------------------ ----------- -------------- -------------------- ----------------- ------- ---------- ------ ------ ------ ------
  Fernandez-Rozadilla [@pone.0100133-FernandezRozadilla2]          2010         Caucasian   Replication         Hospital             0.544         168      436      242    196    411    274
  von Holst S [@pone.0100133-vonHolst1]                            2010         Caucasian   Replication        Population            0.439         573      829      356    533    838    326
  Xiong F [@pone.0100133-Xiong1]                                   2010           Asian     Replication        Population            0.443         583      1091     427    639    1085   399
  Kupfer SS [@pone.0100133-Kupfer1]                                2010          African    Replication         Hospital             0.334         332      319       62    400    418     97
  Kupfer SS [@pone.0100133-Kupfer1]                                2010         Caucasian   Replication         Hospital             0.475         93       183       97    100    163     83
  Ho JW [@pone.0100133-Ho1]                                        2011           Asian     Replication         Hospital             0.522         170      350      195    168    346    199
  Tomlinson (UK1) [@pone.0100133-Tomlinson1]                       2011         Caucasian       GWAS           Population            0.452         233      441      247    274    470    184
  Tomlinson (SCOT1) [@pone.0100133-Tomlinson1]                     2011         Caucasian       GWAS           Population            0.451         256      500      220    294    512    195
  Tomlinson (SCOT2) [@pone.0100133-Tomlinson1]                     2011         Caucasian       GWAS           Population            0.451         540      1017     449    630    999    428
  Tomlinson (VQ58) [@pone.0100133-Tomlinson1]                      2011         Caucasian       GWAS           Population            0.468         503      886      410    773    1312   603
  Tomlinson (CCFR) [@pone.0100133-Tomlinson1]                      2011         Caucasian       GWAS           Population            0.476         290      595      298    274    496    227
  Tomlinson (AU) [@pone.0100133-Tomlinson1]                        2011         Caucasian       GWAS           Population            0.439         124      208      108    129    233     76
  Tomlinson (HEL) [@pone.0100133-Tomlinson1]                       2011         Caucasian   Replication        Population            0.426         272      459      202    273    405    150
  Tomlinson (SEARCH) [@pone.0100133-Tomlinson1]                    2011         Caucasian   Replication        Population            0.471         618      1083     537    650    1086   519
  Tomlinson (COIN/NBS) [@pone.0100133-Tomlinson1]                  2011         Caucasian   Replication        population            0.462         593      1044     510    722    1246   532
  Tomlinson (UK3) [@pone.0100133-Tomlinson1]                       2011         Caucasian   Replication        Population            0.472        2012      3865     1828   1247   2116   1006
  Tomlinson (SCOT3) [@pone.0100133-Tomlinson1]                     2011         Caucasian   Replication        Population            0.455         305      554      268    628    1130   432
  Tomlinson (UK4) [@pone.0100133-Tomlinson1]                       2011         Caucasian   Replication        Population            0.463         141      306      127    288    544    210
  Li FX [@pone.0100133-Li2]                                        2012           Asian     Replication         Hospital             0.468         35       122       58     71    141     54

Abbreviations: GWAS, genome-wide association study; MAF, minor allele frequency (the C allele of rs4444235).

Pooled Frequency of the Risk Allele (the C Allele) in Controls According to Ethnicity {#s3b}
-------------------------------------------------------------------------------------

Significant heterogeneity was seen both in Caucasians and Asians. and thus the random-effect model was applied (all *P*\<0.0001, *I^2^* = 82.21 and 92.40, respectively). The pooled frequency of the C allele was 0.463 (95% CI = 0.452--0.474) in Caucasians, similar to that of 0.477 (95% CI = 0.423--0.532) in Asians. Only 1 study was conducted in Africans, and the frequency of the C allele was 0.334.

Overall Meta-analysis of the rs4444235 and Colorectal Cancer Risk {#s3c}
-----------------------------------------------------------------

[Table 2](#pone-0100133-t002){ref-type="table"} summarizes the results of overall meta-analysis. In the metagen analysis, the pooled OR~TC/TT~ and OR~CC/TT~ were 1.08 (95% CI = 1.03--1.12) and 1.18 (95% CI = 1.12--1.25), respectively, suggesting an additive model as the most plausible genetic model. Then the additive model for the rs4444235 was assessed using traditional method. In the additive model, heterogeneity was observed (*P* = 0.059, *I^2^* = 36.1), and thus the random-effect model was applied. The variant was significantly associated with increased CRC risk, with a pooled per-allele OR of 1.08 (95% CI = 1.05--1.11; [Figure 2](#pone-0100133-g002){ref-type="fig"}). Based on the model-free approach, heterogeneity was also seen (*P* = 0.063, *I^2^* = 35.6). Under the random-effect model, significant result was also produced for the association of rs4444235 and CRC risk, with a pooled OR~G~ of 1.09 (95% CI = 1.05--1.14).

![The forest plot of the association between rs4444235 and colorectal cancer risk in the additive model.](pone.0100133.g002){#pone-0100133-g002}

10.1371/journal.pone.0100133.t002

###### Meta-analysis of rs4444235 and colorectal cancer risk.

![](pone.0100133.t002){#pone-0100133-t002-2}

  Study characteristics         Cases/controls         Genetic model     OR (95%CI)        *I^2\ (^*%)      *P* for heterogeneity  
  ----------------------- --------------------------- --------------- ---------------- ------------------- ----------------------- -------
  Total (N = 19)                                        28770/28234    Additive Model   1.08 (1.04--1.11)           36.1            0.059
                                                                           OR~G~        1.09 (1.05--1.14)           35.6            0.063
  Ethnicity                   Caucasian (N = 15)        25026/24217    Additive Model   1.08 (1.05--1.11)           11.8            0.321
                                 Asian (N = 3)           3031/3102     Additive Model   1.11 (0.95--1.31)           68.9            0.040
                                African (N = 1)           713/915      Additive Model   0.89 (0.77--1.04)                          
                              Caucasian (N = 15)                           OR~G~        1.10 (1.06--1.14)           11.7            0.322
                                 Asian (N = 3)                             OR~G~        1.14 (0.94--1.37)           68.8            0.041
                                African (N = 1)                            OR~G~        0.88 (0.74--1.05)                          
  Sources of controls      Population based (N = 13)    23807/22990    Additive Model   1.08 (1.05--1.12)           16.6            0.277
                            Hospital based (N = 6)       4963/5244     Additive Model   1.05 (0.95--1.15)           59.5            0.030
                           Population based (N = 13)                       OR~G~        1.10 (1.06--1.14)           15.3            0.290
                            Hospital based (N = 6)                         OR~G~        1.06 (0.94--1.18)           59.3            0.031
  Study design                   GWAS (N = 6)            7325/8109     Additive model   1.12 (1.06--1.18)           33.4            0.185
                             Replication (N = 13)       21445/20125    Additive model   1.06 (1.05--1.11)           33.6            0.114
                                 GWAS (N = 6)                              OR~G~        1.14 (1.07--1.22)           31.0            0.203
                             Replication (N = 13)                          OR~G~        1.07 (1.03--1.12)           33.3            0.116
  Total sample size             ≤2000 (N = 10)           6706/7358     Additive model   1.11 (1.03--1.19)           57.6            0.012
                                \>20000 (N = 9)         22064/20876    Additive model   1.07 (1.05--1.11)            0.0            0.674
                                ≤2000 (N = 10)                             OR~G~        1.13 (1.03--1.23)           57.1            0.013
                                \>20000 (N = 9)                            OR~G~        1.08 (1.05--1.12)            0.0            0.666

Abbreviations: GWAS, genome-wide association study; OR, odds ratio; 95% CI, 95% confidence interval; OR~G,~ generalized OR.

Stratification Analysis of the rs4444235 and Colorectal Cancer Risk {#s3d}
-------------------------------------------------------------------

When performed stratified analysis by population ethnicity, in Caucasian subgroup of 15 studies, heterogeneity was removed, and the significant association of the rs4444235 still existed for both additive model and OR~G~ assessment ([Table 2](#pone-0100133-t002){ref-type="table"}). However, in Asians of 3 studies, there was significant heterogeneity (*P* = 0.040 and 0.041 for additive model and OR~G~, respectively), and no significant association was found.

According to the sources of controls, in the population-based subgroup of 13 studies, analysis of the additive model and OR~G~ both showed significant association of rs4444235 with CRC without evidence of heterogeneity, whereas in the hospital-based subgroup of 8 studies, significant heterogeneity was observed and no significant association was reported.

Regarding to study design, there were 6 GWAS and 13 replication studies. When assessing the additive model and OR~G~ metric, both subgroups showed the positive genetic association with CRC risk, without evidence of heterogeneity. Interestingly, the pooled estimates in the GWAS (per-allele OR = 1.12; OR~G~ = 1.14) were slightly larger than those in the subgroup of replication studies (per-allele OR = 1.06; OR~G~ = 1.07).

The stratified analysis was also conducted according to total sample size (numbers of both cases and controls), into 2 subgroups: the large sample size subgroup (total sample size \>2000) with 22064 cases and 20876 controls and the small or moderate size subgroup (total sample size ≤2000) with 6706 cases and 7358 controls. For both additive model and OR~G~ analyses, heterogeneity was removed in the subgroup with large sample size, whereas in the small or moderate size subgroup, heterogeneity still existed. Both subgroups showed the significant association between the rs4444235 and CRC risk.

Sensitivity Analysis and Publication Bias Assessment {#s3e}
----------------------------------------------------

Since between-study heterogeneity was observed in this meta-analysis, we further performed sensitivity analysis under the random-effect model. For the additive model, the sensitivity analysis, by sequentially omitting each study, reported a series of pooled OR with 95% CI exceeding 1.00, and the pooled ORs were similar before and after omitting each study ([Table 3](#pone-0100133-t003){ref-type="table"}). Similar results were suggested for OR~G~ analysis that no single study significantly altered the pooled OR~G~. In the Begg's and the Egger's tests, there was no evidence of publication bias for both additive model and OR~G~ (all *P* values for Begg's and Egger's tests \>0.05).

10.1371/journal.pone.0100133.t003

###### Sensitivity analysis of rs4444235 and colorectal cancer risk.

![](pone.0100133.t003){#pone-0100133-t003-3}

  Omitted study                                                Additive model     OR~G~                                     
  ---------------------------------------------------------- ------------------- ------- ------ ------------------- ------- ------
  Fernandez (EPICOLON) [@pone.0100133-FernandezRozadilla2]    1.08 (1.05--1.12)   0.059   37.0   1.10 (1.06--1.14)   0.065   35.9
  von Holst [@pone.0100133-vonHolst1]                         1.08 (1.05--1.12)   0.082   33.6   1.10 (1.06--1.14)   0.091   32.4
  Xiong (Beijing) [@pone.0100133-Xiong1]                      1.08 (1.04--1.12)   0.043   39.6   1.09 (1.05--1.14)   0.046   39.0
  Kupfer (UC) [@pone.0100133-Kupfer1]                         1.08 (1.05--1.12)   0.173   23.8   1.10 (1.06--1.14)   0.174   23.7
  Kupfer (UNC) [@pone.0100133-Kupfer1]                        1.08 (1.04--1.11)   0.045   39.3   1.09 (1.05--1.14)   0.048   38.7
  Ho (HK) [@pone.0100133-Ho1]                                 1.08 (1.05--1.12)   0.062   36.4   1.10 (1.06--1.14)   0.066   35.8
  Tomlinson (UK1) [@pone.0100133-Tomlinson1]                  1.07 (1.04--1.10)   0.159   25.2   1.08 (1.05--1.12)   0.164   24.6
  Tomlinson (SCOT1) [@pone.0100133-Tomlinson1]                1.08 (1.04--1.11)   0.053   37.9   1.09 (1.05--1.13)   0.056   37.4
  Tomlinson (SCOT2) [@pone.0100133-Tomlinson1]                1.08 (1.04--1.11)   0.051   38.3   1.09 (1.05--1.14)   0.055   37.5
  Tomlinson (VQ58) [@pone.0100133-Tomlinson1]                 1.08 (1.05--1.12)   0.062   36.5   1.10 (1.06--1.14)   0.065   36.0
  Tomlinson (CCFR) [@pone.0100133-Tomlinson1]                 1.08 (1.04--1.11)   0.047   38.9   1.09 (1.05--1.14)   0.051   38.3
  Tomlinson (AU) [@pone.0100133-Tomlinson1]                   1.08 (1.04--1.11)   0.057   37.2   1.09 (1.05--1.13)   0.058   37.0
  Tomlinson (HEL) [@pone.0100133-Tomlinson1]                  1.08 (1.04--1.11)   0.060   36.7   1.09 (1.05--1.13)   0.064   36.2
  Tomlinson (SEARCH) [@pone.0100133-Tomlinson1]               1.08 (1.05--1.12)   0.049   38.5   1.10 (1.05--1.14)   0.052   38.0
  Tomlinson (COIN/NBS) [@pone.0100133-Tomlinson1]             1.08 (1.04--1.12)   0.043   39.7   1.09 (1.05--1.14)   0.046   39.1
  Tomlinson (UK3) [@pone.0100133-Tomlinson1]                  1.08 (1.04--1.12)   0.045   39.3   1.10 (1.05--1.14)   0.047   38.9
  Tomlinson (SCOT3) [@pone.0100133-Tomlinson1]                1.08 (1.04--1.11)   0.052   38.0   1.09 (1.05--1.14)   0.054   37.7
  Tomlinson (UK4) [@pone.0100133-Tomlinson1]                  1.08 (1.04--1.11)   0.045   39.2   1.09 (1.05--1.14)   0.049   38.6
  Li (Jiangxi) [@pone.0100133-Li2]                            1.07 (1.04--1.11)   0.145   26.5   1.09 (1.05--1.13)   0.153   25.7

Abbreviations: OR, odds ratio; 95% CI, 95% confidence interval; OR~G,~ generalized OR.

\**P* values for heterogeneity were calculated by the Cochran's χ^2^ based Q test.

Discussion {#s4}
==========

Currently, traditional meta-analyses of genetic association studies are usually performed by collapsing genotypes in two categories assuming various genetic models. However, these different models are not independent, and a priori biological justification for the choice of a specific model is seldom available [@pone.0100133-Kavvoura1]. Additionally, interpretation of these results is complicated since a set of different estimates and significance tests are usually provided. In this current meta-analysis of rs4444235 and colorectal cancer risk, we utilized a comprehensive strategy, including the metagen analysis based on logistic regression and OR~G~ metric based on model-free approach [@pone.0100133-Bagos1], [@pone.0100133-Zintzaras1], to overcome the drawbacks in traditional meta-analysis of erroneous model specification and multiple model tests with an inflated Type I error rate, and make the interpretation of the current results easier.

In this meta-analysis of 19 case-control studies of 28770 cases and 28234 controls, the metagen analysis indicated that the rs4444235 fitted best to an additive model. Knowledge of the best-fitting model for the rs4444235 may be important in optimizing the use of this SNP in colorectal cancer (CRC) risk prediction. Assessment of additive model indicated that CRC risk was increased by 8% per extra C allele. Based on model-free approach, the generalized OR (OR~G~) analysis showed that CRC cases with higher mutational load than healthy individuals have 9% higher risk for CRC susceptibility. Sensitivity analysis further supported the current results, by showing similar ORs before and after sequentially omitting single study. The positive association of the rs4444235 with CRC risk identified by this meta-analysis was also concordant with the findings of previous meta-analyses [@pone.0100133-Li1], [@pone.0100133-Theodoratou1].

rs4444235 is 9.4 kb from the transcription start site of the *BMP4*. The BMP signaling has vital function in maintenance of Wnt signaling to inhibit differentiation of stem cell near colorectal crypt bases [@pone.0100133-Hardwick1]. Heightened expression of BMP pathway members would restrain the Wnt signaling, subsequently activate β-catenin and elevate cells susceptibility to tumor-causing mutations, and ultimately promote colorectal carcinogenesis [@pone.0100133-Hardwick1]. Intriguingly, in a recent study, luciferase reporter assay suggested the element to which rs4444235 maps acts as an allele-specific transcriptional enhancer [@pone.0100133-Lubbe3]. In CRC cell lines allele-specific expression analysis indicated a significant association of increased *BMP4* expression with the C allele [@pone.0100133-Lubbe3]. These data have strongly supported the functional role of rs4444235 in CRC development through the cis-acting regulatory influence on *BMP4* expression.

Heterogeneity is a pervasive and difficult problem in meta-analysis of genetic association studies. Not surprisingly, heterogeneity existed in this meta-analysis, and thus the findings should be interpreted with caution. Nevertheless, in stratified analysis by ethnicity, heterogeneity was removed in Caucasians and significant association of rs4444235 retained. According to study design, both in GWAS and replication studies, heterogeneity was effectively decreased, and association was also existed. Interestingly, the subgroup of GWAS yielded larger pooled ORs than that in replication data, indicating "winner curse" existed for the rs4444235 in GWAS. In regarding to sample size, only in the subgroup with large sample size heterogeneity was removed, but both subgroups showed significant genetic association. When stratified by sources of controls, heterogeneity was removed in population-based subgroup. These findings suggested the heterogeneity could be in part explained by the distinct natures of population ethnicity, control sources, study design, and sample size across individual studies. Furthermore, no single study had significant influence on the overall estimates in sensitivity analysis, and no publication bias was observed in this meta-analysis, suggesting the robust stability of the current results.

Despite the strength of this study utilizing a comprehensive statistical strategy, some limitations merit serious consideration. In stratified analysis by ethnicity, majority of studies were conducted in Caucasians, only 3 studies and 1 study appraised rs4444235 in Asians and Africans, respectively. No association was seen in Asians and Africans possibly due to small sample size and insufficient power. The relationship of rs4444235 and CRC risk merits more studies in various populations. Only one polymorphism was assessed in this meta-analysis, and this meta-analysis did not give a global view of the genetic variants of *BMP4* in CRC susceptibility. Additionally, gene-environment interactions did play more important role in colorectal carcinogenesis as compared with genetic factors [@pone.0100133-Zhong2]. However, only one study so far by Hutter et al. has explored interaction of rs4444235 and environmental factors [@pone.0100133-Hutter1], and thus the interaction could not be appraised in this meta-analysis.

In conclusion, this updated meta-analysis, utilizing a comprehensive strategy, further supports the significant role of rs4444235 in genetic susceptibility of colorectal cancer. Further functional polymorphism-based studies in the whole *BMP4* gene are warranted to confirm and extend the current findings in various ethnical populations.
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